Thurs. Jan. 17
5:30 pm, ESB 1001

Watch Video

Jim Andelman
General Partner, Rincon Venture Partners
http://www.rinconvp.com/Team.htm
Served as a Principal at Broadview Capital Partners.
Former member of the Technology Investment Banking Group at Deutsche Banc Alex, Brown.

Thurs. Jan. 31
5:30 pm
ESB 1001

Watch Video

 

Chet Sandberg, P.E.
Altair Nanotechnologies
http://www.altairnano.com
Technical Strategy Manager, Altairnano.
Formerly worked with the Chemelex Division at Raychem Corporation.
Managed development of technology for Shell Oil.

Thurs. Feb. 7
5:30 pm
ESB 1001

Watch Video

 

Bruce Lyon
Chief Executive Officer
Integrated Media Technologies, Inc.
http://www.imtglobalinc.com
Integrated Media Technologies Inc. is a leading provider of products and services for video, storage, and information technology consulting. IMT’s unique value is built on a team of award winning media technology professionals - engineers, software developers, architects, and account executives dedicated to solving each customer’s technology problems with innovative and cost effective solutions in partnership with the world’s best technology companies.

Thurs. Feb. 14
5:30 pm
ESB 1001

Watch Video

 

  
Krisztina M. Zsebo, Ph.D.
CEO Celladon Corporation

http://www.celladon.net/index.php
  

Dr. Zsebo is a biopharmaceutical veteran with 24 years of experience in the industry, Dr. Zsebo has been involved in numerous successful ventures. She is CEO of Celladon Corporation, La Jolla, CA. Prior to joining Celladon, she was a Venture Partner at Enterprise Partners Venture Capital, and held executive positions at Remedyne Corporation, Connetics, ALZA, Cell Genesys, and Amgen.

At ALZA Corporation Dr. Zsebo was responsible for the division which developed and filed the NDA for Viadur, an implantable drug/device for prostate cancer patients now marketed by Bayer Corporation. At Cell Genesys, where she was Executive Vice President of Research and Product Development, she was responsible for filing their first IND for a gene therapy product for AIDS. She also managed Cell Genesys' Xenotech division, which was spun off to become Abgenix, one of the most successful biotech companies. Earlier in her career, Kris spent eight years at Amgen in research and product development where she worked on the discovery of NEUPOGEN, as well as STEMGEN, and various aspects of EPOGEN development.

Thurs. Feb. 28
5:30 pm
ESB 1001

Watch Video

 

Alexander Manu
Chief Imaginator, InnoSpa International Partners
http://www.manuinnospainternational.blogspot.com

Alexander Manu is a strategic innovation practitioner, lecturer, and author. He is a Senior Partner and Chief Imaginator at InnoSpa International Partners, a worldwide consulting firm reshaping business thinking by helping large corporations explore and define new competitive spaces. He is also a Professor at the Ontario College of Art and Design and teaches “Strategic Foresight for Pre-Competitive Innovation” at the Rotman School of Management in Toronto.